Trials / Sponsors / Mediar Therapeutics
Mediar Therapeutics
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease Healthy Adult Participants, Diabetic Kidney Disease | Phase 1 | 2026-05-01 |
| Recruiting | EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc) Diffuse Cutaneous Systemic Sclerosis | Phase 2 | 2026-05-01 |
| Completed | Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males Healthy Adult Male | Phase 1 | 2026-02-18 |
| Recruiting | WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF) Idiopathic Pulmonary Fibrosis | Phase 2 | 2025-05-05 |
| Completed | A First-in-Human Safety Trial of MTX-474 Healthy | Phase 1 | 2024-07-10 |
| Completed | A First-in-Human Safety Trial of MTX-463 Healthy | Phase 1 | 2024-04-15 |